Zhou, Qingzhang
Tian, Wenhong
Liu, Chunguo
Lian, Zhonghui
Dong, Xiaoyan
Wu, Xiaobing
Article History
Received: 7 December 2016
Accepted: 9 May 2017
First Online: 14 July 2017
Competing Interests
: Mr. Chunguo Liu and Dr. Xiaoyan Dong are employees of Beijing FivePlus Molecular Medicine Institute, Ltd. Dr. Xiaoyan Dong is the stockholder of the company. None of the other authors declare conflicts of interest.